Literature DB >> 11861706

A new defect of peroxisomal function involving pristanic acid: a case report.

B N McLean1, J Allen, S Ferdinandusse, R J A Wanders.   

Abstract

AN adult onset novel disorder of peroxisomal function is described, characterised by retinitis pigmentosa resulting in progressive visual failure, learning difficulties, a peripheral neuropathy, and hypogonadism. The defect results in accumulation of pristanic acid, and the bile acid intermediates, dihydroxycholestanoic and trihydroxycholestanoic acid, and is due to a deficiency of alpha-methylacyl-CoA racemase, making this the first fully characterised description of this defect. Screening of patients with retinitis pigmentosa should be extended to include pristanic acid and/or bile acid intermediate concentrations, as dietary measures offer a potential treatment for the disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861706      PMCID: PMC1737782          DOI: 10.1136/jnnp.72.3.396

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  AMACR mutations cause late-onset autosomal recessive cerebellar ataxia.

Authors:  David Dick; Rita Horvath; Patrick F Chinnery
Journal:  Neurology       Date:  2011-05-17       Impact factor: 9.910

2.  Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.

Authors:  S Ferdinandusse; P Kostopoulos; S Denis; H Rusch; H Overmars; U Dillmann; W Reith; D Haas; R J A Wanders; M Duran; M Marziniak
Journal:  Am J Hum Genet       Date:  2006-03-29       Impact factor: 11.025

3.  Neurochemical evidence that pristanic acid impairs energy production and inhibits synaptic Na(+), K(+)-ATPase activity in brain of young rats.

Authors:  Estela Natacha Brandt Busanello; Carolina Maso Viegas; Anelise Miotti Tonin; Mateus Grings; Alana Pimentel Moura; Anderson Büker de Oliveira; Paula Eichler; Moacir Wajner
Journal:  Neurochem Res       Date:  2011-03-29       Impact factor: 3.996

4.  Relapsing encephalopathy in a patient with α-methylacyl-CoA racemase deficiency.

Authors:  Sian A Thompson; Jacqui Calvin; Sarah Hogg; Sacha Ferdinandusse; Ronald J A Wanders; Roger A Barker
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 5.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

6.  An adult onset case of alpha-methyl-acyl-CoA racemase deficiency.

Authors:  Emily Helen Smith; Dimitar K Gavrilov; Devin Oglesbee; William D Freeman; Michael W Vavra; Dietrich Matern; Silvia Tortorelli
Journal:  J Inherit Metab Dis       Date:  2010-09-04       Impact factor: 4.982

7.  MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing.

Authors:  Kristoffer Haugarvoll; Stefan Johansson; Charalampos Tzoulis; Bjørn Ivar Haukanes; Cecilie Bredrup; Gesche Neckelmann; Helge Boman; Per Morten Knappskog; Laurence A Bindoff
Journal:  Orphanet J Rare Dis       Date:  2013-01-03       Impact factor: 4.123

Review 8.  Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases.

Authors:  Gyeyeong Kong; Hyunji Lee; Quangdon Tran; Chaeyeong Kim; Nayoung Gong; Jisoo Park; So Hee Kwon; Seon-Hwan Kim; Jongsun Park
Journal:  Front Mol Biosci       Date:  2020-07-14

9.  Asymptomatic retinal dysfunction in alpha-methylacyl-CoA racemase deficiency.

Authors:  Abrar K Alsalamah; Arif O Khan
Journal:  Mol Vis       Date:  2021-07-01       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.